COVID-19 Impact on Global Molecular Diagnostics Cancer Market Size, Status and Forecast 2020-2026

August 2020 | 127 pages | ID: C9AFB31CCC4AEN
QYResearch

Abstracts

This report focuses on the global Molecular Diagnostics Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Roche
• Danaher
• Siemens
• Abbott Laboratories
• ICON Plc
• AstraZeneca
• MDxHealth
• Invitae
• PlexBio
• Thermo Fisher Scientific
• Guardant Health
• Biocartis
• Bio-Techne
• Merck
• Foundation Medicine
• 10X Genomics
• Biodesix
• CytoTrack
• GenomOncology
• Luminex

Market segment by Type, the product can be split into

• Pharmacogenomic Diagnosis
• Liquid Biopsy
• Other

Market segment by Application, split into

• Respiratory Cancer
• Cancer of Digestive System
• Cancer of Urinary System
• Cancer of Circulatory System
• Motor System Cancer
• Reproductive System Cancer
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Molecular Diagnostics Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Molecular Diagnostics Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Molecular Diagnostics Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Pharmacogenomic Diagnosis
  1.4.3 Liquid Biopsy
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Respiratory Cancer
  1.5.3 Cancer of Digestive System
  1.5.4 Cancer of Urinary System
  1.5.5 Cancer of Circulatory System
  1.5.6 Motor System Cancer
  1.5.7 Reproductive System Cancer
  1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostics Cancer Industry Impact
  1.6.1 How the Covid-19 is Affecting the Molecular Diagnostics Cancer Industry
    1.6.1.1 Molecular Diagnostics Cancer Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Molecular Diagnostics Cancer Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Molecular Diagnostics Cancer Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Molecular Diagnostics Cancer Market Perspective (2015-2026)
2.2 Molecular Diagnostics Cancer Growth Trends by Regions
  2.2.1 Molecular Diagnostics Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Molecular Diagnostics Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Molecular Diagnostics Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Molecular Diagnostics Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Molecular Diagnostics Cancer Players by Market Size
  3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2015-2020)
  3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnostics Cancer Market Concentration Ratio
  3.2.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2019
3.3 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.4 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.5 Date of Enter into Molecular Diagnostics Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2021-2026)

5 MOLECULAR DIAGNOSTICS CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Molecular Diagnostics Cancer Market Size by Application (2015-2020)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Molecular Diagnostics Cancer Market Size (2015-2020)
6.2 Molecular Diagnostics Cancer Key Players in North America (2019-2020)
6.3 North America Molecular Diagnostics Cancer Market Size by Type (2015-2020)
6.4 North America Molecular Diagnostics Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Molecular Diagnostics Cancer Market Size (2015-2020)
7.2 Molecular Diagnostics Cancer Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnostics Cancer Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnostics Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Molecular Diagnostics Cancer Market Size (2015-2020)
8.2 Molecular Diagnostics Cancer Key Players in China (2019-2020)
8.3 China Molecular Diagnostics Cancer Market Size by Type (2015-2020)
8.4 China Molecular Diagnostics Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Molecular Diagnostics Cancer Market Size (2015-2020)
9.2 Molecular Diagnostics Cancer Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnostics Cancer Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnostics Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Molecular Diagnostics Cancer Market Size (2015-2020)
10.2 Molecular Diagnostics Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnostics Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnostics Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Molecular Diagnostics Cancer Market Size (2015-2020)
11.2 Molecular Diagnostics Cancer Key Players in India (2019-2020)
11.3 India Molecular Diagnostics Cancer Market Size by Type (2015-2020)
11.4 India Molecular Diagnostics Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Molecular Diagnostics Cancer Market Size (2015-2020)
12.2 Molecular Diagnostics Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnostics Cancer Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnostics Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Molecular Diagnostics Cancer Introduction
  13.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Danaher
  13.2.1 Danaher Company Details
  13.2.2 Danaher Business Overview and Its Total Revenue
  13.2.3 Danaher Molecular Diagnostics Cancer Introduction
  13.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.2.5 Danaher Recent Development
13.3 Siemens
  13.3.1 Siemens Company Details
  13.3.2 Siemens Business Overview and Its Total Revenue
  13.3.3 Siemens Molecular Diagnostics Cancer Introduction
  13.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.3.5 Siemens Recent Development
13.4 Abbott Laboratories
  13.4.1 Abbott Laboratories Company Details
  13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
  13.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.4.5 Abbott Laboratories Recent Development
13.5 ICON Plc
  13.5.1 ICON Plc Company Details
  13.5.2 ICON Plc Business Overview and Its Total Revenue
  13.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
  13.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.5.5 ICON Plc Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
  13.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 MDxHealth
  13.7.1 MDxHealth Company Details
  13.7.2 MDxHealth Business Overview and Its Total Revenue
  13.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
  13.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.7.5 MDxHealth Recent Development
13.8 Invitae
  13.8.1 Invitae Company Details
  13.8.2 Invitae Business Overview and Its Total Revenue
  13.8.3 Invitae Molecular Diagnostics Cancer Introduction
  13.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.8.5 Invitae Recent Development
13.9 PlexBio
  13.9.1 PlexBio Company Details
  13.9.2 PlexBio Business Overview and Its Total Revenue
  13.9.3 PlexBio Molecular Diagnostics Cancer Introduction
  13.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.9.5 PlexBio Recent Development
13.10 Thermo Fisher Scientific
  13.10.1 Thermo Fisher Scientific Company Details
  13.10.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  13.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
  13.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  13.10.5 Thermo Fisher Scientific Recent Development
13.11 Guardant Health
  10.11.1 Guardant Health Company Details
  10.11.2 Guardant Health Business Overview and Its Total Revenue
  10.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
  10.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.11.5 Guardant Health Recent Development
13.12 Biocartis
  10.12.1 Biocartis Company Details
  10.12.2 Biocartis Business Overview and Its Total Revenue
  10.12.3 Biocartis Molecular Diagnostics Cancer Introduction
  10.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.12.5 Biocartis Recent Development
13.13 Bio-Techne
  10.13.1 Bio-Techne Company Details
  10.13.2 Bio-Techne Business Overview and Its Total Revenue
  10.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
  10.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.13.5 Bio-Techne Recent Development
13.14 Merck
  10.14.1 Merck Company Details
  10.14.2 Merck Business Overview and Its Total Revenue
  10.14.3 Merck Molecular Diagnostics Cancer Introduction
  10.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.14.5 Merck Recent Development
13.15 Foundation Medicine
  10.15.1 Foundation Medicine Company Details
  10.15.2 Foundation Medicine Business Overview and Its Total Revenue
  10.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
  10.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.15.5 Foundation Medicine Recent Development
13.16 10X Genomics
  10.16.1 10X Genomics Company Details
  10.16.2 10X Genomics Business Overview and Its Total Revenue
  10.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
  10.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.16.5 10X Genomics Recent Development
13.17 Biodesix
  10.17.1 Biodesix Company Details
  10.17.2 Biodesix Business Overview and Its Total Revenue
  10.17.3 Biodesix Molecular Diagnostics Cancer Introduction
  10.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.17.5 Biodesix Recent Development
13.18 CytoTrack
  10.18.1 CytoTrack Company Details
  10.18.2 CytoTrack Business Overview and Its Total Revenue
  10.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
  10.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.18.5 CytoTrack Recent Development
13.19 GenomOncology
  10.19.1 GenomOncology Company Details
  10.19.2 GenomOncology Business Overview and Its Total Revenue
  10.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
  10.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.19.5 GenomOncology Recent Development
13.20 Luminex
  10.20.1 Luminex Company Details
  10.20.2 Luminex Business Overview and Its Total Revenue
  10.20.3 Luminex Molecular Diagnostics Cancer Introduction
  10.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2015-2020)
  10.20.5 Luminex Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Molecular Diagnostics Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
Table 3. Ranking of Global Top Molecular Diagnostics Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacogenomic Diagnosis
Table 6. Key Players of Liquid Biopsy
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Molecular Diagnostics Cancer Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Molecular Diagnostics Cancer Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Molecular Diagnostics Cancer Players to Combat Covid-19 Impact
Table 13. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Molecular Diagnostics Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Molecular Diagnostics Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Molecular Diagnostics Cancer Market Share by Regions (2015-2020)
Table 17. Global Molecular Diagnostics Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Molecular Diagnostics Cancer Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Molecular Diagnostics Cancer Market Growth Strategy
Table 23. Main Points Interviewed from Key Molecular Diagnostics Cancer Players
Table 24. Global Molecular Diagnostics Cancer Revenue by Players (2015-2020) (Million US$)
Table 25. Global Molecular Diagnostics Cancer Market Share by Players (2015-2020)
Table 26. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2019)
Table 27. Global Molecular Diagnostics Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Molecular Diagnostics Cancer Product Solution and Service
Table 30. Date of Enter into Molecular Diagnostics Cancer Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 33. Global Molecular Diagnostics Cancer Market Size Share by Type (2015-2020)
Table 34. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2021-2026)
Table 35. Global Molecular Diagnostics Cancer Market Size Share by Application (2015-2020)
Table 36. Global Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 37. Global Molecular Diagnostics Cancer Market Size Share by Application (2021-2026)
Table 38. North America Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 40. North America Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 41. North America Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 42. North America Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 43. North America Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 44. Europe Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 46. Europe Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 48. Europe Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 50. China Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 51. China Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 52. China Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 53. China Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 54. China Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 55. China Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 56. Japan Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 58. Japan Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 60. Japan Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 64. Southeast Asia Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 66. Southeast Asia Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 68. India Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 69. India Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 70. India Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 71. India Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 72. India Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 73. India Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 76. Central & South America Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 78. Central & South America Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Danaher Company Details
Table 86. Danaher Business Overview
Table 87. Danaher Product
Table 88. Danaher Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 89. Danaher Recent Development
Table 90. Siemens Company Details
Table 91. Siemens Business Overview
Table 92. Siemens Product
Table 93. Siemens Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 94. Siemens Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Product
Table 98. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 99. Abbott Laboratories Recent Development
Table 100. ICON Plc Company Details
Table 101. ICON Plc Business Overview
Table 102. ICON Plc Product
Table 103. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 104. ICON Plc Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Product
Table 108. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 109. AstraZeneca Recent Development
Table 110. MDxHealth Company Details
Table 111. MDxHealth Business Overview
Table 112. MDxHealth Product
Table 113. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 114. MDxHealth Recent Development
Table 115. Invitae Business Overview
Table 116. Invitae Product
Table 117. Invitae Company Details
Table 118. Invitae Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 119. Invitae Recent Development
Table 120. PlexBio Company Details
Table 121. PlexBio Business Overview
Table 122. PlexBio Product
Table 123. PlexBio Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 124. PlexBio Recent Development
Table 125. Thermo Fisher Scientific Company Details
Table 126. Thermo Fisher Scientific Business Overview
Table 127. Thermo Fisher Scientific Product
Table 128. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 129. Thermo Fisher Scientific Recent Development
Table 130. Guardant Health Company Details
Table 131. Guardant Health Business Overview
Table 132. Guardant Health Product
Table 133. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 134. Guardant Health Recent Development
Table 135. Biocartis Company Details
Table 136. Biocartis Business Overview
Table 137. Biocartis Product
Table 138. Biocartis Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 139. Biocartis Recent Development
Table 140. Bio-Techne Company Details
Table 141. Bio-Techne Business Overview
Table 142. Bio-Techne Product
Table 143. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 144. Bio-Techne Recent Development
Table 145. Merck Company Details
Table 146. Merck Business Overview
Table 147. Merck Product
Table 148. Merck Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 149. Merck Recent Development
Table 150. Foundation Medicine Company Details
Table 151. Foundation Medicine Business Overview
Table 152. Foundation Medicine Product
Table 153. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 154. Foundation Medicine Recent Development
Table 155. 10X Genomics Company Details
Table 156. 10X Genomics Business Overview
Table 157. 10X Genomics Product
Table 158. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 159. 10X Genomics Recent Development
Table 160. Biodesix Company Details
Table 161. Biodesix Business Overview
Table 162. Biodesix Product
Table 163. Biodesix Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 164. Biodesix Recent Development
Table 165. CytoTrack Company Details
Table 166. CytoTrack Business Overview
Table 167. CytoTrack Product
Table 168. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 169. CytoTrack Recent Development
Table 170. GenomOncology Company Details
Table 171. GenomOncology Business Overview
Table 172. GenomOncology Product
Table 173. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 174. GenomOncology Recent Development
Table 175. Luminex Company Details
Table 176. Luminex Business Overview
Table 177. Luminex Product
Table 178. Luminex Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 179. Luminex Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2020 VS 2026
Figure 2. Pharmacogenomic Diagnosis Features
Figure 3. Liquid Biopsy Features
Figure 4. Other Features
Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2026
Figure 6. Respiratory Cancer Case Studies
Figure 7. Cancer of Digestive System Case Studies
Figure 8. Cancer of Urinary System Case Studies
Figure 9. Cancer of Circulatory System Case Studies
Figure 10. Motor System Cancer Case Studies
Figure 11. Reproductive System Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Molecular Diagnostics Cancer Report Years Considered
Figure 14. Global Molecular Diagnostics Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Molecular Diagnostics Cancer Market Share by Regions: 2020 VS 2026
Figure 16. Global Molecular Diagnostics Cancer Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Molecular Diagnostics Cancer Market Share by Players in 2019
Figure 19. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2019
Figure 21. North America Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 30. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 32. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 34. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 36. ICON Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 38. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 40. MDxHealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 42. Invitae Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 44. PlexBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 46. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 48. Guardant Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 50. Biocartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 52. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 54. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 56. Foundation Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 58. 10X Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 60. Biodesix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 62. CytoTrack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 64. GenomOncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 66. Luminex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed